🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07538037
Recruiting Not applicable

Effects of Low-Intensity Blood Flow Restriction Training on Strength and Kicking Performance in Taekwondo Athletes

NCT07538037 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai University of Sport
Phase
Not applicable
Started
2026-04-10
Last updated
2026-04-20

Condition(s) studied

Physical PerformanceAthletic Performance

Investigational drug(s) / intervention(s)

LI-BFRTHIRT

LI-BFRT: Low-intensity resistance training combined with blood flow restriction applied to the proximal limbs.

HIRT: Conventional high-intensity resistance training without blood flow restriction.

Study summary

This study aims to investigate the effects of low-intensity blood flow restriction training (LI-BFRT) on lower-limb strength and kicking performance in taekwondo athletes. Blood flow restriction training is a method that partially restricts blood flow to the muscles during exercise, which may improve performance while reducing training load.

Eligibility

Sex
ALL
Min age
16 Years
Max age
25 Years
Healthy volunteers
Accepted
Inclusion Criteria: \- Taekwondo athletes aged 16-25 years National-level athletes (National Level 1 or higher); Minimum of 3 years of systematic taekwondo training experience; Free from lower-limb injury within the past 6 months; Able to complete the training intervention and testing procedures. Exclusion Criteria: \- History of cardiovascular, metabolic, or neurological disorders; Current musculoskeletal injury or pain affecting training; Participation in other structured resistance training programs during the study period; Use of medications or supplements that may affect physical performance Inability or unwillingness to provide informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai University of Sport Shanghai Shanghai Municipality Recruiting

More Shanghai University of Sport trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07538037 on ClinicalTrials.gov ↗ ← All trials in China